Terence Beghyn

590 total citations
15 papers, 465 citations indexed

About

Terence Beghyn is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Terence Beghyn has authored 15 papers receiving a total of 465 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Organic Chemistry and 3 papers in Pharmacology. Recurrent topics in Terence Beghyn's work include Chemical synthesis and alkaloids (3 papers), Phosphodiesterase function and regulation (3 papers) and Cholinesterase and Neurodegenerative Diseases (2 papers). Terence Beghyn is often cited by papers focused on Chemical synthesis and alkaloids (3 papers), Phosphodiesterase function and regulation (3 papers) and Cholinesterase and Neurodegenerative Diseases (2 papers). Terence Beghyn collaborates with scholars based in France, United States and Belgium. Terence Beghyn's co-authors include Benoît Déprez, Rebecca Deprez‐Poulain, Nicolas Willand, Julie Charton, Marion Flipo, Vincent Leroux, Benoı̂t Folléas, Dieter C. Gruenert, Vincent Mouly and Jieshuang Jia and has published in prestigious journals such as Analytical Biochemistry, Journal of Controlled Release and Journal of Medicinal Chemistry.

In The Last Decade

Terence Beghyn

14 papers receiving 461 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Terence Beghyn France	11	278	120	67	64	48	15	465
Lianhu Wei Canada	13	246 0.9×	153 1.3×	34 0.5×	55 0.9×	37 0.8×	26	465
Fang Yuan China	10	127 0.5×	120 1.0×	129 1.9×	88 1.4×	35 0.7×	21	443
Toshihiro Imaeda Japan	11	334 1.2×	138 1.1×	37 0.6×	29 0.5×	36 0.8×	20	597
Soňa Gurská Czechia	17	354 1.3×	258 2.1×	26 0.4×	66 1.0×	47 1.0×	63	680
Gilles A. Robichaud Canada	18	527 1.9×	102 0.8×	31 0.5×	106 1.7×	43 0.9×	53	927
Mark E. Zupec United States	15	326 1.2×	115 1.0×	43 0.6×	91 1.4×	59 1.2×	18	546
Shoukath M. Ali United States	12	316 1.1×	97 0.8×	19 0.3×	66 1.0×	89 1.9×	28	548
Nicola Relitti Italy	12	223 0.8×	95 0.8×	50 0.7×	60 0.9×	58 1.2×	20	423
Hong‐Rae Kim South Korea	10	198 0.7×	91 0.8×	35 0.5×	36 0.6×	27 0.6×	33	350
Biswajit Pal India	15	358 1.3×	64 0.5×	86 1.3×	24 0.4×	58 1.2×	36	627

Countries citing papers authored by Terence Beghyn

Since Specialization

Citations

This map shows the geographic impact of Terence Beghyn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Terence Beghyn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Terence Beghyn more than expected).

Fields of papers citing papers by Terence Beghyn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Terence Beghyn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Terence Beghyn. The network helps show where Terence Beghyn may publish in the future.

Co-authorship network of co-authors of Terence Beghyn

This figure shows the co-authorship network connecting the top 25 collaborators of Terence Beghyn. A scholar is included among the top collaborators of Terence Beghyn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Terence Beghyn. Terence Beghyn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Grand, Katheryn, Pedro A. Sanchez‐Lara, Thierry Levade, et al.. (2025). Acid Ceramidase Deficiency. Neurology Genetics. 11(2). e200243–e200243.

Paquot, Adrien, Benoît Déprez, & Terence Beghyn. (2024). Drug repurposing and phenotypic screening: innovative strategies for treating ultra-rare disorders. Frontiers in Medicine. 11. 1489094–1489094. 2 indexed citations

Paquot, Adrien, Gustavo Soto Ares, Anne‐Frédérique Dessein, et al.. (2024). Findings from the individualized management of a patient with Acyl-CoA Oxidase-1 (ACOX1) deficiency: A bedside-to-bench-to-bedside strategy. Molecular Genetics and Metabolism. 143(3). 108581–108581. 2 indexed citations

Deplanque, Dominique, Philippe Lechat, Terence Beghyn, et al.. (2022). Drug repurposing: From the discovery of a useful pharmacological effect to making the treatment available to the patient. Therapies. 78(1). 10–18. 3 indexed citations

Leroux, Florence, Damien Bosc, Terence Beghyn, et al.. (2019). Identification of ebselen as a potent inhibitor of insulin degrading enzyme by a drug repurposing screening. European Journal of Medicinal Chemistry. 179. 557–566. 13 indexed citations

Henninot, Antoine, et al.. (2015). Characterization of monoclonal antibodies by a fast and easy liquid chromatography–mass spectrometry time-of-flight analysis on culture supernatant. Analytical Biochemistry. 491. 52–54. 12 indexed citations

Karrout, Y., Laurent Dubuquoy, Catherine Piveteau, et al.. (2014). In vivo efficacy of microbiota-sensitive coatings for colon targeting: A promising tool for IBD therapy. Journal of Controlled Release. 197. 121–130. 38 indexed citations

Gonzalez-Hilarion, Sara, Terence Beghyn, Jieshuang Jia, et al.. (2012). Rescue of nonsense mutations by amlexanox in human cells. Orphanet Journal of Rare Diseases. 7(1). 58–58. 124 indexed citations

Beghyn, Terence, Julie Charton, Florence Leroux, et al.. (2011). Drug to Genome to Drug: Discovery of New Antiplasmodial Compounds. Journal of Medicinal Chemistry. 54(9). 3222–3240. 49 indexed citations

10.

Beghyn, Terence, Julie Charton, Florence Leroux, et al.. (2011). Drug-to-Genome-to-Drug, Step 2: Reversing Selectivity in a Series of Antiplasmodial Compounds. Journal of Medicinal Chemistry. 55(3). 1274–1286. 18 indexed citations

11.

Beghyn, Terence, Rebecca Deprez‐Poulain, Nicolas Willand, Benoı̂t Folléas, & Benoît Déprez. (2008). Natural Compounds: Leads or Ideas? Bioinspired Molecules for Drug Discovery. Chemical Biology & Drug Design. 72(1). 3–15. 67 indexed citations

12.

Flipo, Marion, Terence Beghyn, Vincent Leroux, et al.. (2007). Novel Selective Inhibitors of the Zinc Plasmodial Aminopeptidase PfA-M1 as Potential Antimalarial Agents. Journal of Medicinal Chemistry. 50(6). 1322–1334. 60 indexed citations

13.

Beghyn, Terence, Candide Hounsou, & Benoît Déprez. (2006). PDE5 inhibitors: An original access to novel potent arylated analogues of tadalafil. Bioorganic & Medicinal Chemistry Letters. 17(3). 789–792. 28 indexed citations

14.

Flipo, Marion, Terence Beghyn, Julie Charton, et al.. (2006). A library of novel hydroxamic acids targeting the metallo-protease family: Design, parallel synthesis and screening. Bioorganic & Medicinal Chemistry. 15(1). 63–76. 29 indexed citations

15.

Willand, Nicolas, et al.. (2003). Synthesis and structural studies of a novel scaffold for drug discovery: a 4,5-dihydro-3H-spiro[1,5-benzoxazepine-2,4′-piperidine]. Tetrahedron Letters. 45(5). 1051–1054. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact